Evaluation of topical povidone-iodine ointment in experimental burn wound sepsis.
D000818:Animals; D001344:Autopsy; D001706:Biopsy; D002056:Burns / Q000150:complications*; D005069:Evaluation Studies as Topic; D008099:Liver / Q000382:microbiology; D008168:Lung / Q000382:microbiology; D008297:Male; D011205:Povidone / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa; D051381:Rats; D012834:Silver / Q000627:therapeutic use; D013154:Spleen / Q000382:microbiology; D013411:Sulfadiazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013997:Time Factors; D014105:Tosyl Compounds / Q000627:therapeutic use; D014774:Virulence; D014946:Wound Infection / Q000188:drug therapy*
D013449:Sulfonamides; D014105:Tosyl Compounds; D013411:Sulfadiazine; D012834:Silver; D011205:Povidone